T
TRML
Tourmaline Bio
This stock has been delisted.
News
Press Releases
Financial Reports
Profile
Reuters·01/21 15:38
BUZZ-Zura Bio names new CEO; shares rise
Benzinga·10/29/2025 13:54
Cantor Fitzgerald Suspends Overweight Rating on Tourmaline Bio
Simply Wall St·10/29/2025 02:19
Tourmaline Bio (TRML): Evaluating Valuation After Recent Strong Share Price Gains
Reuters·10/28/2025 16:13
Tourmaline Bio Inc. Files Initial Beneficial Ownership Statement Naming Novartis AG
TipRanks·10/28/2025 14:58
Tourmaline Bio to Delist from Nasdaq and Deregister
Reuters·10/28/2025 14:43
Tourmaline Bio Inc. Completes Merger and Terminates $100 Million ATM Sales Agreement
TipRanks·10/28/2025 14:10
Tourmaline Bio acquisition completed by Novartis
Seeking Alpha·10/28/2025 08:13
Novartis Q3 profit swells as oncology drugs drive growth
Reuters·10/28/2025 06:26
BRIEF-Novartis Announces Expiration Of Tourmaline Bio Tender Offer
TipRanks·10/27/2025 19:52
Tourmaline Bio’s Promising Phase 2b Study on Thyroid Eye Disease Treatment
Seeking Alpha·10/25/2025 15:00
Microsoft, Meta Set To Report Earnings As Investors Watch Out For Trump-Xi, Fed Meeting
Seeking Alpha·10/24/2025 19:00
Catalyst Watch: Trump-Xi, Fed meeting, Honeywell spinoff, and Amazon headlines busy earnings week
TipRanks·10/22/2025 11:06
Novartis announces expiration of HSR Act waiting period of Tourmaline Bio offer
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.